| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 2.20e-08 | 5 | 27 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 1.23e-07 | 8 | 27 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 3.61e-07 | 11 | 27 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 7.95e-07 | 14 | 27 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | glycine-gated chloride ion channel activity | 1.76e-06 | 2 | 27 | 2 | GO:0022852 | |
| GeneOntologyMolecularFunction | vasoactive intestinal polypeptide receptor activity | 5.28e-06 | 3 | 27 | 2 | GO:0004999 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.44e-06 | 193 | 27 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 6.01e-06 | 197 | 27 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 1.05e-05 | 4 | 27 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 1.28e-05 | 34 | 27 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.40e-05 | 35 | 27 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxygen binding | 1.66e-05 | 37 | 27 | 3 | GO:0019825 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 1.76e-05 | 5 | 27 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 1.76e-05 | 5 | 27 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.62e-05 | 43 | 27 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 2.63e-05 | 6 | 27 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 2.63e-05 | 6 | 27 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 2.63e-05 | 6 | 27 | 2 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 2.63e-05 | 6 | 27 | 2 | GO:0016934 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 3.68e-05 | 7 | 27 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 3.90e-05 | 49 | 27 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 4.14e-05 | 50 | 27 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 4.91e-05 | 8 | 27 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 4.91e-05 | 8 | 27 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 4.91e-05 | 8 | 27 | 2 | GO:0005237 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 6.71e-05 | 793 | 27 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.58e-05 | 334 | 27 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 7.81e-05 | 171 | 27 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.17e-04 | 1180 | 27 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.51e-04 | 77 | 27 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | glycine binding | 1.59e-04 | 14 | 27 | 2 | GO:0016594 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.83e-04 | 15 | 27 | 2 | GO:0016725 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.09e-04 | 86 | 27 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | transporter activity | 2.17e-04 | 1289 | 27 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 3.02e-04 | 1353 | 27 | 8 | GO:0004888 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.34e-04 | 459 | 27 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 3.56e-04 | 103 | 27 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 4.92e-04 | 115 | 27 | 3 | GO:0004497 | |
| GeneOntologyMolecularFunction | channel activity | 6.16e-04 | 525 | 27 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.22e-04 | 526 | 27 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.28e-04 | 125 | 27 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 7.52e-04 | 133 | 27 | 3 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 8.72e-04 | 140 | 27 | 3 | GO:0001653 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.09e-03 | 151 | 27 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | heme binding | 1.15e-03 | 154 | 27 | 3 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.38e-03 | 164 | 27 | 3 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.43e-03 | 166 | 27 | 3 | GO:0005506 | |
| GeneOntologyMolecularFunction | demethylase activity | 1.61e-03 | 44 | 27 | 2 | GO:0032451 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.22e-03 | 194 | 27 | 3 | GO:0016705 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 2.50e-03 | 55 | 27 | 2 | GO:0017046 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.13e-03 | 758 | 27 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.47e-03 | 65 | 27 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.47e-03 | 65 | 27 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | amino acid binding | 4.36e-03 | 73 | 27 | 2 | GO:0016597 | |
| GeneOntologyMolecularFunction | organic acid binding | 4.75e-03 | 254 | 27 | 3 | GO:0043177 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 6.03e-03 | 884 | 27 | 5 | GO:0004930 | |
| GeneOntologyMolecularFunction | amide binding | 7.45e-03 | 299 | 27 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 8.03e-03 | 100 | 27 | 2 | GO:0030594 | |
| GeneOntologyMolecularFunction | hormone binding | 8.50e-03 | 103 | 27 | 2 | GO:0042562 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.16e-02 | 664 | 27 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | steroid binding | 1.39e-02 | 133 | 27 | 2 | GO:0005496 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.53e-02 | 140 | 27 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 1.87e-02 | 766 | 27 | 4 | GO:0016491 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.00e-02 | 1189 | 27 | 5 | GO:0046914 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 1.49e-07 | 9 | 26 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 3.88e-07 | 12 | 26 | 3 | GO:0070989 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GLRA3 CCR2 SLC8B1 P2RX2 SLC34A1 ADCYAP1R1 GLRA2 HTT CNGB3 TTYH2 | 4.91e-07 | 1115 | 26 | 10 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GLRA3 CCR2 SLC8B1 P2RX2 SLC34A1 ADCYAP1R1 GLRA2 HTT CNGB3 TTYH2 | 3.30e-06 | 1374 | 26 | 10 | GO:0006811 |
| GeneOntologyBiologicalProcess | demethylation | 3.54e-06 | 24 | 26 | 3 | GO:0070988 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 1.00e-05 | 412 | 26 | 6 | GO:0006066 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 1.06e-05 | 641 | 26 | 7 | GO:1901615 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 1.52e-05 | 5 | 26 | 2 | GO:0009822 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.70e-05 | 40 | 26 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 2.05e-05 | 273 | 26 | 5 | GO:0034764 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 2.28e-05 | 134 | 26 | 4 | GO:0098661 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 2.40e-05 | 1017 | 26 | 8 | GO:0098660 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 3.77e-05 | 52 | 26 | 3 | GO:0008210 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 3.99e-05 | 53 | 26 | 3 | GO:0042572 | |
| GeneOntologyBiologicalProcess | mycotoxin metabolic process | 4.26e-05 | 8 | 26 | 2 | GO:0043385 | |
| GeneOntologyBiologicalProcess | aflatoxin metabolic process | 4.26e-05 | 8 | 26 | 2 | GO:0046222 | |
| GeneOntologyBiologicalProcess | organic heteropentacyclic compound metabolic process | 4.26e-05 | 8 | 26 | 2 | GO:1901376 | |
| GeneOntologyBiologicalProcess | alkaloid metabolic process | 5.47e-05 | 9 | 26 | 2 | GO:0009820 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 7.22e-05 | 180 | 26 | 4 | GO:0015698 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 9.27e-05 | 192 | 26 | 4 | GO:0034767 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 1.10e-04 | 389 | 26 | 5 | GO:0055074 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.49e-04 | 217 | 26 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.88e-04 | 89 | 26 | 3 | GO:0001523 | |
| GeneOntologyBiologicalProcess | toxin metabolic process | 2.05e-04 | 17 | 26 | 2 | GO:0009404 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 2.21e-04 | 94 | 26 | 3 | GO:0016101 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 2.23e-04 | 1395 | 26 | 8 | GO:0007186 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 3.06e-04 | 105 | 26 | 3 | GO:0006721 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 3.15e-04 | 106 | 26 | 3 | GO:0034308 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport into cytosol | 3.16e-04 | 21 | 26 | 2 | GO:0010524 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 3.23e-04 | 266 | 26 | 4 | GO:0043270 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 3.42e-04 | 109 | 26 | 3 | GO:1904427 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 3.70e-04 | 112 | 26 | 3 | GO:1902476 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound biosynthetic process | 3.77e-04 | 277 | 26 | 4 | GO:1901617 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 4.25e-04 | 286 | 26 | 4 | GO:0042445 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 4.43e-04 | 525 | 26 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | cellular response to ethanol | 4.50e-04 | 25 | 26 | 2 | GO:0071361 | |
| GeneOntologyBiologicalProcess | polyol metabolic process | 4.87e-04 | 123 | 26 | 3 | GO:0019751 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport into cytosol | 5.26e-04 | 27 | 26 | 2 | GO:0010522 | |
| GeneOntologyBiologicalProcess | chloride transport | 5.47e-04 | 128 | 26 | 3 | GO:0006821 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | 5.66e-04 | 28 | 26 | 2 | GO:0071294 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 5.72e-04 | 130 | 26 | 3 | GO:0060079 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 5.72e-04 | 130 | 26 | 3 | GO:0097306 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 5.89e-04 | 559 | 26 | 5 | GO:0042391 | |
| GeneOntologyBiologicalProcess | response to alcohol | 5.90e-04 | 312 | 26 | 4 | GO:0097305 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 6.72e-04 | 323 | 26 | 4 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 6.80e-04 | 577 | 26 | 5 | GO:0043269 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 6.95e-04 | 31 | 26 | 2 | GO:1901623 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 7.25e-04 | 141 | 26 | 3 | GO:0006805 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | 7.47e-04 | 589 | 26 | 5 | GO:0034762 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 7.70e-04 | 144 | 26 | 3 | GO:0006720 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 8.18e-04 | 147 | 26 | 3 | GO:0099565 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 9.18e-04 | 153 | 26 | 3 | GO:0098656 | |
| GeneOntologyBiologicalProcess | alcohol biosynthetic process | 9.36e-04 | 154 | 26 | 3 | GO:0046165 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 9.36e-04 | 154 | 26 | 3 | GO:0051928 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 9.36e-04 | 942 | 26 | 6 | GO:0098655 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 9.54e-04 | 622 | 26 | 5 | GO:0098771 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 9.90e-04 | 37 | 26 | 2 | GO:0042178 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 9.97e-04 | 359 | 26 | 4 | GO:0006874 | |
| GeneOntologyBiologicalProcess | response to ethanol | 1.06e-03 | 161 | 26 | 3 | GO:0045471 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.18e-03 | 376 | 26 | 4 | GO:0008202 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.27e-03 | 663 | 26 | 5 | GO:0050804 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 1.28e-03 | 42 | 26 | 2 | GO:0060402 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.28e-03 | 664 | 26 | 5 | GO:0099177 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 1.33e-03 | 174 | 26 | 3 | GO:1904064 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.38e-03 | 392 | 26 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | 1.38e-03 | 676 | 26 | 5 | GO:0044283 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.46e-03 | 684 | 26 | 5 | GO:0010817 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.47e-03 | 180 | 26 | 3 | GO:0060078 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 1.47e-03 | 180 | 26 | 3 | GO:0120254 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 1.52e-03 | 1035 | 26 | 6 | GO:0019752 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.54e-03 | 183 | 26 | 3 | GO:0006820 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 1.63e-03 | 1048 | 26 | 6 | GO:0014070 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 1.67e-03 | 705 | 26 | 5 | GO:0055080 | |
| GeneOntologyBiologicalProcess | response to metal ion | 1.70e-03 | 415 | 26 | 4 | GO:0010038 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 1.71e-03 | 1058 | 26 | 6 | GO:0043436 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 1.73e-03 | 417 | 26 | 4 | GO:0034765 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 1.76e-03 | 1064 | 26 | 6 | GO:0006082 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 1.79e-03 | 717 | 26 | 5 | GO:0050801 | |
| GeneOntologyBiologicalProcess | sensory perception | 1.82e-03 | 1072 | 26 | 6 | GO:0007600 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 1.95e-03 | 731 | 26 | 5 | GO:0032787 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 2.02e-03 | 53 | 26 | 2 | GO:0048247 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 2.25e-03 | 209 | 26 | 3 | GO:0006694 | |
| GeneOntologyBiologicalProcess | lipid modification | 2.40e-03 | 214 | 26 | 3 | GO:0030258 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 2.50e-03 | 59 | 26 | 2 | GO:0045761 | |
| GeneOntologyCellularComponent | chloride channel complex | 5.37e-05 | 57 | 27 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | glycinergic synapse | 3.01e-04 | 20 | 27 | 2 | GO:0098690 | |
| Domain | Cyt_P450_E_grp-II | 2.69e-08 | 5 | 27 | 3 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 5.37e-08 | 6 | 27 | 3 | IPR008072 | |
| Domain | Glycine_rcpt_A | 1.21e-05 | 4 | 27 | 2 | IPR008127 | |
| Domain | Cyt_P450_CS | 6.01e-05 | 53 | 27 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 7.48e-05 | 57 | 27 | 3 | PS00086 | |
| Domain | p450 | 7.88e-05 | 58 | 27 | 3 | PF00067 | |
| Domain | Cyt_P450 | 8.73e-05 | 60 | 27 | 3 | IPR001128 | |
| Domain | GABAA/Glycine_rcpt | 5.00e-04 | 23 | 27 | 2 | IPR006028 | |
| Domain | HormR | 5.92e-04 | 25 | 27 | 2 | SM00008 | |
| Domain | HRM | 7.43e-04 | 28 | 27 | 2 | PF02793 | |
| Domain | GPCR_2_secretin-like_CS | 1.10e-03 | 34 | 27 | 2 | IPR017983 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.52e-03 | 40 | 27 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.52e-03 | 40 | 27 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 1.52e-03 | 40 | 27 | 2 | IPR001879 | |
| Domain | Cyt_P450_E_grp-I | 1.92e-03 | 45 | 27 | 2 | IPR002401 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.92e-03 | 45 | 27 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 2.00e-03 | 46 | 27 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 2.09e-03 | 47 | 27 | 2 | PF02931 | |
| Domain | Neur_channel | 2.09e-03 | 47 | 27 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.09e-03 | 47 | 27 | 2 | IPR006202 | |
| Domain | Neurotrans-gated_channel_TM | 2.09e-03 | 47 | 27 | 2 | IPR006029 | |
| Domain | NEUROTR_ION_CHANNEL | 2.09e-03 | 47 | 27 | 2 | PS00236 | |
| Domain | - | 2.09e-03 | 47 | 27 | 2 | 2.70.170.10 | |
| Domain | HEAT | 2.18e-03 | 48 | 27 | 2 | PF02985 | |
| Domain | 7tm_2 | 2.36e-03 | 50 | 27 | 2 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.36e-03 | 50 | 27 | 2 | PS00650 | |
| Domain | - | 3.16e-03 | 58 | 27 | 2 | 1.10.630.10 | |
| Domain | HEAT | 3.16e-03 | 58 | 27 | 2 | IPR000357 | |
| Domain | GPCR_2-like | 3.38e-03 | 60 | 27 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 3.38e-03 | 60 | 27 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.49e-03 | 61 | 27 | 2 | PS50261 | |
| Domain | HEAT_REPEAT | 4.57e-03 | 70 | 27 | 2 | PS50077 | |
| Domain | 7TM_GPCR_Srsx | 1.13e-02 | 112 | 27 | 2 | SM01381 | |
| Domain | ARM-type_fold | 1.26e-02 | 339 | 27 | 3 | IPR016024 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.74e-06 | 272 | 23 | 6 | M13380 | |
| Pathway | REACTOME_XENOBIOTICS | 6.58e-06 | 23 | 23 | 3 | M5372 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 7.51e-06 | 24 | 23 | 3 | M46445 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 1.35e-05 | 29 | 23 | 3 | M2920 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 1.82e-05 | 32 | 23 | 3 | M39567 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 7.09e-05 | 8 | 23 | 2 | MM1547 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 7.51e-05 | 51 | 23 | 3 | M17726 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 9.42e-05 | 55 | 23 | 3 | M14933 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.11e-04 | 157 | 23 | 4 | M4904 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.35e-04 | 62 | 23 | 3 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.48e-04 | 64 | 23 | 3 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.48e-04 | 64 | 23 | 3 | M9488 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.66e-04 | 12 | 23 | 2 | M39611 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.66e-04 | 12 | 23 | 2 | MM15616 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.93e-04 | 70 | 23 | 3 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.10e-04 | 72 | 23 | 3 | M9257 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.64e-04 | 15 | 23 | 2 | MM15697 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.83e-04 | 18 | 23 | 2 | MM14843 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 4.28e-04 | 19 | 23 | 2 | M27449 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 5.25e-04 | 21 | 23 | 2 | M39631 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 5.77e-04 | 22 | 23 | 2 | MM15614 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 6.20e-04 | 104 | 23 | 3 | M738 | |
| Pathway | REACTOME_PREDNISONE_ADME | 6.31e-04 | 23 | 23 | 2 | MM16639 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 6.88e-04 | 24 | 23 | 2 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 6.88e-04 | 24 | 23 | 2 | M39643 | |
| Pathway | REACTOME_XENOBIOTICS | 7.47e-04 | 25 | 23 | 2 | MM14846 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 7.50e-04 | 111 | 23 | 3 | M48065 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 8.08e-04 | 26 | 23 | 2 | MM15190 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.15e-03 | 31 | 23 | 2 | M39476 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.23e-03 | 32 | 23 | 2 | M27900 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 1.30e-03 | 33 | 23 | 2 | MM1448 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 1.30e-03 | 33 | 23 | 2 | M10322 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 1.30e-03 | 33 | 23 | 2 | MM15066 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.56e-03 | 143 | 23 | 3 | MM15055 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.59e-03 | 144 | 23 | 3 | MM14501 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.42e-03 | 45 | 23 | 2 | MM15694 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 2.52e-03 | 46 | 23 | 2 | M39828 | |
| Pathway | WP_PANCREATIC_CANCER_SUBTYPES | 2.74e-03 | 48 | 23 | 2 | M48093 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 3.15e-03 | 183 | 23 | 3 | M39588 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 4.12e-03 | 59 | 23 | 2 | MM15838 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 4.26e-03 | 60 | 23 | 2 | MM14964 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.33e-03 | 205 | 23 | 3 | M752 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 4.68e-03 | 63 | 23 | 2 | M27862 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.69e-03 | 211 | 23 | 3 | MM14502 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 4.80e-03 | 702 | 23 | 5 | M746 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 5.13e-03 | 66 | 23 | 2 | MM14839 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.27e-03 | 220 | 23 | 3 | M10320 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 5.87e-03 | 736 | 23 | 5 | M27287 | |
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 4.17e-10 | 3 | 27 | 3 | 32001245 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 32146629 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 19801957 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 4.17e-10 | 3 | 27 | 3 | 23143891 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 33866277 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 20621111 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 17582393 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 4.17e-10 | 3 | 27 | 3 | 20615193 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 20118548 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 34688813 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 18978522 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 34689350 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 24168324 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 14559847 | ||
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 4.17e-09 | 5 | 27 | 3 | 11266076 | |
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 11093772 | ||
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 1.46e-08 | 7 | 27 | 3 | 11137287 | |
| Pubmed | 1.46e-08 | 7 | 27 | 3 | 19842932 | ||
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 20147896 | ||
| Pubmed | 4.99e-08 | 10 | 27 | 3 | 12865317 | ||
| Pubmed | 9.14e-08 | 12 | 27 | 3 | 15319333 | ||
| Pubmed | Sequence diversity and haplotype structure at the human CYP3A cluster. | 1.19e-07 | 13 | 27 | 3 | 16314882 | |
| Pubmed | 2.82e-07 | 17 | 27 | 3 | 19424794 | ||
| Pubmed | 4.60e-07 | 81 | 27 | 4 | 22723691 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 4.71e-07 | 20 | 27 | 3 | 9890157 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22399754 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27225724 | ||
| Pubmed | Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. | 5.80e-07 | 2 | 27 | 2 | 11930171 | |
| Pubmed | Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip. | 5.80e-07 | 2 | 27 | 2 | 16207150 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15634941 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 28986474 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26615671 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 28704257 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15900284 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 18058330 | ||
| Pubmed | Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer. | 5.80e-07 | 2 | 27 | 2 | 36688864 | |
| Pubmed | Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5. | 5.80e-07 | 2 | 27 | 2 | 16684709 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15900215 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23491640 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17460031 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 33638195 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31309254 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19343327 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21380731 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22696420 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35998509 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19907160 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 7894497 | ||
| Pubmed | Influence of CYP3A polymorphisms on tacrolimus pharmacokinetics in kidney transplant recipients. | 5.80e-07 | 2 | 27 | 2 | 32843687 | |
| Pubmed | Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients. | 5.80e-07 | 2 | 27 | 2 | 17605821 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27841150 | ||
| Pubmed | Association of genotypes of the CYP3A cluster with midazolam disposition in vivo. | 5.80e-07 | 2 | 27 | 2 | 19506580 | |
| Pubmed | Comparison of catalytic properties of cytochromes P450 3A4 and 3A5 by molecular docking simulation. | 5.80e-07 | 2 | 27 | 2 | 24484539 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35471917 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17495880 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22096084 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29227563 | ||
| Pubmed | Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. | 5.80e-07 | 2 | 27 | 2 | 15379787 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 18625318 | ||
| Pubmed | [Influence of CYP3A4/5 polymorphisms in the pharmacokinetics of levonorgestrel: a pilot study]. | 5.80e-07 | 2 | 27 | 2 | 23715232 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24469018 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 36581339 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22645092 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15882469 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 33512723 | ||
| Pubmed | Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels. | 5.80e-07 | 2 | 27 | 2 | 27382060 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30166405 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29475834 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24989928 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23459029 | ||
| Pubmed | CYP3A genes and the association between prenatal methylmercury exposure and neurodevelopment. | 5.80e-07 | 2 | 27 | 2 | 28500872 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25976223 | ||
| Pubmed | Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma. | 5.80e-07 | 2 | 27 | 2 | 25370902 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 28784756 | ||
| Pubmed | Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors. | 5.80e-07 | 2 | 27 | 2 | 25689036 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 33886687 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 36379901 | ||
| Pubmed | The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience. | 5.80e-07 | 2 | 27 | 2 | 36396462 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23223499 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30926609 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21513075 | ||
| Pubmed | The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine. | 5.80e-07 | 2 | 27 | 2 | 23780963 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27349315 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25385241 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19591893 | ||
| Pubmed | CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population. | 5.80e-07 | 2 | 27 | 2 | 15698606 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20630055 | ||
| Pubmed | CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer. | 5.80e-07 | 2 | 27 | 2 | 14504207 | |
| Pubmed | CYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 Cells. | 5.80e-07 | 2 | 27 | 2 | 36623883 | |
| Pubmed | Decision tree-based modeling of androgen pathway genes and prostate cancer risk. | 5.80e-07 | 2 | 27 | 2 | 21493872 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31064695 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26654672 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22993851 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26772622 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 14515058 | ||
| Pubmed | The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose. | 5.80e-07 | 2 | 27 | 2 | 14515059 | |
| Pubmed | Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. | 5.80e-07 | 2 | 27 | 2 | 26921389 | |
| Pubmed | Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. | 5.80e-07 | 2 | 27 | 2 | 11940601 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26521259 | ||
| Pubmed | Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue. | 5.80e-07 | 2 | 27 | 2 | 8877031 | |
| Interaction | CYP3A5 interactions | 4.16e-07 | 12 | 26 | 3 | int:CYP3A5 | |
| Interaction | CYP3A7 interactions | 2.39e-05 | 6 | 26 | 2 | int:CYP3A7 | |
| Cytoband | 7q21.1 | 9.31e-06 | 8 | 27 | 2 | 7q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 2.88e-04 | 219 | 27 | 3 | chr7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q42 | 8.76e-03 | 240 | 27 | 2 | chr1q42 | |
| GeneFamily | Cytochrome P450 family 3 | 7.53e-08 | 8 | 21 | 3 | 1002 | |
| GeneFamily | Vasoactive intestinal peptide receptor family | 3.85e-06 | 3 | 21 | 2 | 264 | |
| GeneFamily | Glycine receptors | 1.28e-05 | 5 | 21 | 2 | 868 | |
| Coexpression | PRC2_EZH2_UP.V1_DN | 4.29e-05 | 192 | 27 | 4 | M2737 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN | 4.93e-05 | 199 | 27 | 4 | M8265 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 4.93e-05 | 199 | 27 | 4 | M9173 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP | 4.93e-05 | 199 | 27 | 4 | M7821 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_UP | 5.03e-05 | 200 | 27 | 4 | M5675 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON | 6.26e-05 | 75 | 27 | 3 | M5278 | |
| Coexpression | YAMASHITA_LIVER_CANCER_STEM_CELL_DN | 6.52e-05 | 76 | 27 | 3 | M9206 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 1.06e-04 | 15 | 27 | 2 | M1141 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 1.92e-04 | 20 | 27 | 2 | MM1104 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.81e-06 | 188 | 27 | 4 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-06 | 192 | 27 | 4 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 98 | 27 | 3 | cb0941481aef9068d7dbce0d1b6cf125f482a98d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 98 | 27 | 3 | a74fb790c135bd0d0033df3aca7b789d8b25e361 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.40e-05 | 129 | 27 | 3 | 64768adf23123b92280fb30eb85147cbee084ae0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 154 | 27 | 3 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 154 | 27 | 3 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 154 | 27 | 3 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 154 | 27 | 3 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.15e-04 | 157 | 27 | 3 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 161 | 27 | 3 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 166 | 27 | 3 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-04 | 166 | 27 | 3 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 169 | 27 | 3 | 225aec04ba762d4c55885257de03a65b63503fbb | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 169 | 27 | 3 | 278960f940b646a788360b1c84d641a8d169896b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 180 | 27 | 3 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-04 | 180 | 27 | 3 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.83e-04 | 184 | 27 | 3 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-04 | 185 | 27 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 187 | 27 | 3 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 187 | 27 | 3 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 187 | 27 | 3 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-04 | 187 | 27 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | wk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.95e-04 | 188 | 27 | 3 | 3f3a744b2615bf72f6119f26087099110c0d21fc | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.98e-04 | 189 | 27 | 3 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 193 | 27 | 3 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 193 | 27 | 3 | aaf681f16f310168e4719464814a1fc0a2f8431a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 194 | 27 | 3 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-04 | 198 | 27 | 3 | bfd720e2dae3b6b3dc2bf8b2096c554fd456e756 | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.31e-04 | 199 | 27 | 3 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 199 | 27 | 3 | 51be0e3a91d1f25454b56d55ef6342ef8e8df4e8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-04 | 200 | 27 | 3 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | de23a5d22d94935802b5b84a9e029b3f62c57028 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | 0ff2607c58bc929e203f407ecf3605e0b21bfa90 | |
| Computational | Genes in the cancer module 27. | 1.24e-04 | 355 | 16 | 5 | MODULE_27 | |
| Computational | AcetylCholine receptors. | 1.87e-04 | 14 | 16 | 2 | MODULE_328 | |
| Computational | Cytochrome P450. | 1.87e-04 | 14 | 16 | 2 | MODULE_106 | |
| Computational | Genes in the cancer module 267. | 2.16e-04 | 15 | 16 | 2 | MODULE_267 | |
| Computational | Neurotransmitter (GABA) receptor. | 2.16e-04 | 15 | 16 | 2 | MODULE_215 | |
| Computational | Genes in the cancer module 141. | 2.46e-04 | 16 | 16 | 2 | MODULE_141 | |
| Computational | Signaling. | 3.04e-04 | 230 | 16 | 4 | MODULE_176 | |
| Computational | Genes in the cancer module 146. | 4.25e-04 | 102 | 16 | 3 | MODULE_146 | |
| Computational | Genes in the cancer module 112. | 4.84e-04 | 260 | 16 | 4 | MODULE_112 | |
| Computational | Genes in the cancer module 135. | 6.11e-04 | 25 | 16 | 2 | MODULE_135 | |
| Computational | Ion channels. | 7.13e-04 | 27 | 16 | 2 | MODULE_214 | |
| Computational | Oxidoreductases. | 2.27e-03 | 182 | 16 | 3 | MODULE_93 | |
| Computational | Neighborhood of IGFBP1 | 3.16e-03 | 57 | 16 | 2 | CAR_IGFBP1 | |
| Computational | Porins / transporters. | 3.46e-03 | 211 | 16 | 3 | MODULE_63 | |
| Computational | Ion channels. | 4.73e-03 | 70 | 16 | 2 | MODULE_316 | |
| Drug | Alfentanil | 2.97e-08 | 6 | 27 | 3 | ctd:D015760 | |
| Drug | bilobalide | 4.21e-08 | 30 | 27 | 4 | CID000073581 | |
| Drug | halothane | 6.22e-08 | 314 | 27 | 7 | CID000003562 | |
| Drug | phosphodiesterase 4 inhibitor | 9.00e-08 | 36 | 27 | 4 | CID000656969 | |
| Drug | S 840 | 1.24e-07 | 9 | 27 | 3 | CID000096338 | |
| Drug | 4-hydroxymidazolam | 1.77e-07 | 10 | 27 | 3 | CID000124449 | |
| Drug | Ticalopride | 2.44e-07 | 11 | 27 | 3 | CID000216236 | |
| Drug | Troleandomycin | 2.44e-07 | 11 | 27 | 3 | ctd:D014217 | |
| Drug | colchicoside | 3.25e-07 | 12 | 27 | 3 | CID000092763 | |
| Drug | propionanilide | 5.37e-07 | 14 | 27 | 3 | CID000012107 | |
| Drug | 7-BFC | 5.37e-07 | 14 | 27 | 3 | CID000848780 | |
| Drug | noralfentanil | 1.00e-06 | 17 | 27 | 3 | CID000162172 | |
| Drug | aflatoxin | 1.20e-06 | 18 | 27 | 3 | CID000014421 | |
| Drug | Azamulinum | 1.20e-06 | 18 | 27 | 3 | CID003086060 | |
| Drug | Fenthion | 1.20e-06 | 18 | 27 | 3 | ctd:D005284 | |
| Drug | AC1L1SX8 | 1.20e-06 | 18 | 27 | 3 | CID000060278 | |
| Drug | 4-hydroxymidazolam | 1.35e-06 | 2 | 27 | 2 | ctd:C042940 | |
| Drug | norverapamil | 1.35e-06 | 2 | 27 | 2 | ctd:C016904 | |
| Drug | 5,6-dihydro-2H-pyran-2-one | 1.35e-06 | 2 | 27 | 2 | CID000520660 | |
| Drug | 6 beta-hydroxytestosterone | 1.35e-06 | 2 | 27 | 2 | ctd:C025591 | |
| Drug | notopterol | 1.35e-06 | 2 | 27 | 2 | CID005320227 | |
| Drug | N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide | 1.35e-06 | 2 | 27 | 2 | ctd:C114289 | |
| Drug | CQA 206-291 | 1.35e-06 | 2 | 27 | 2 | ctd:C059483 | |
| Drug | fructus schizandrae, radix ginseng, radix ophiopogonis drug combination | 1.35e-06 | 2 | 27 | 2 | ctd:C009252 | |
| Drug | rabeprazole | 1.42e-06 | 19 | 27 | 3 | CID000005029 | |
| Drug | CID5475388 | 1.67e-06 | 20 | 27 | 3 | CID005475388 | |
| Drug | ethyltrimethylammonium | 1.95e-06 | 21 | 27 | 3 | CID000033993 | |
| Drug | diazepam | 2.60e-06 | 189 | 27 | 5 | CID000003016 | |
| Drug | 5-hydroxythalidomide | 2.96e-06 | 24 | 27 | 3 | ctd:C544471 | |
| Drug | 1,4-naphthoquinone | 3.80e-06 | 26 | 27 | 3 | ctd:C035342 | |
| Drug | erythralosamine | 4.06e-06 | 3 | 27 | 2 | CID000352196 | |
| Drug | 3-methoxymorphinan | 4.06e-06 | 3 | 27 | 2 | ctd:C028657 | |
| Drug | dechloroethylcyclophosphamide | 4.06e-06 | 3 | 27 | 2 | ctd:C064445 | |
| Drug | 6 beta-hydroxydexamethasone | 4.06e-06 | 3 | 27 | 2 | CID000063050 | |
| Drug | territrem C | 4.06e-06 | 3 | 27 | 2 | CID000160306 | |
| Drug | 17-hydroxypregnenolone sulfate | 4.06e-06 | 3 | 27 | 2 | CID000152971 | |
| Drug | N-acetyl-S-pentachloro-1,3-butadienylcysteine | 4.06e-06 | 3 | 27 | 2 | ctd:C049739 | |
| Drug | 1-hydroxymethylmidazolam | 4.06e-06 | 3 | 27 | 2 | ctd:C040081 | |
| Drug | tienilic acid | 4.26e-06 | 93 | 27 | 4 | CID000038409 | |
| Drug | C14845 | 4.27e-06 | 27 | 27 | 3 | CID011954064 | |
| Drug | BP-9,10-oxide | 4.27e-06 | 27 | 27 | 3 | CID000037456 | |
| Drug | Brn 4136738 | 4.27e-06 | 27 | 27 | 3 | CID000050331 | |
| Drug | tariquidar | 4.27e-06 | 27 | 27 | 3 | CID000148201 | |
| Drug | 1,2-dichlorobenzene | 4.78e-06 | 28 | 27 | 3 | CID000007239 | |
| Drug | 9-OH-BaP-4,5-oxide | 4.78e-06 | 28 | 27 | 3 | CID000115064 | |
| Drug | BN52020 | 4.78e-06 | 28 | 27 | 3 | CID000115221 | |
| Drug | BDCM | 5.32e-06 | 29 | 27 | 3 | CID000006359 | |
| Drug | SR-12813 | 5.32e-06 | 29 | 27 | 3 | CID000446313 | |
| Drug | Pro 46Ae | 5.32e-06 | 29 | 27 | 3 | CID005485153 | |
| Drug | 11-H-14,15-EETA | 5.91e-06 | 30 | 27 | 3 | CID011954058 | |
| Drug | 19-hydroxytestosterone | 5.91e-06 | 30 | 27 | 3 | CID000150968 | |
| Drug | 1-methylxanthine (1-MX | 6.54e-06 | 31 | 27 | 3 | CID000080220 | |
| Drug | BP-7,8-oxide | 7.21e-06 | 32 | 27 | 3 | CID000037455 | |
| Drug | dimethadione | 7.21e-06 | 32 | 27 | 3 | CID000003081 | |
| Drug | SureCN1562346 | 7.92e-06 | 33 | 27 | 3 | CID011646228 | |
| Drug | 1-naphthol | 7.92e-06 | 33 | 27 | 3 | ctd:C029350 | |
| Drug | B253 | 8.11e-06 | 4 | 27 | 2 | CID000021540 | |
| Drug | iso-THAZ | 8.11e-06 | 4 | 27 | 2 | CID003047783 | |
| Drug | 5-methoxyflavone | 8.11e-06 | 4 | 27 | 2 | CID000094525 | |
| Drug | azacyclonol | 8.11e-06 | 4 | 27 | 2 | CID000015722 | |
| Drug | Picrotoxin | 8.11e-06 | 4 | 27 | 2 | DB00466 | |
| Drug | Ro 23-7637 | 8.11e-06 | 4 | 27 | 2 | CID000129491 | |
| Drug | protostrychnine | 8.11e-06 | 4 | 27 | 2 | CID005320746 | |
| Drug | 7-nitroindoline | 8.11e-06 | 4 | 27 | 2 | CID013566747 | |
| Drug | 2-(phosphonomethyl)phenylalanine | 8.11e-06 | 4 | 27 | 2 | CID000383689 | |
| Drug | SC-49648 | 8.11e-06 | 4 | 27 | 2 | CID000195696 | |
| Drug | N-ethyl-3-toluamide | 8.11e-06 | 4 | 27 | 2 | ctd:C454678 | |
| Drug | akuammiline | 8.11e-06 | 4 | 27 | 2 | CID005367018 | |
| Drug | hydroxytrimipramine | 8.11e-06 | 4 | 27 | 2 | CID000160610 | |
| Drug | NSC381080 | 8.11e-06 | 4 | 27 | 2 | CID000165497 | |
| Drug | N-methyl-THIP | 8.11e-06 | 4 | 27 | 2 | CID000134373 | |
| Drug | SC-48981 | 8.11e-06 | 4 | 27 | 2 | CID000126573 | |
| Drug | SC-50132 | 8.11e-06 | 4 | 27 | 2 | CID000195719 | |
| Drug | CQA 206-291 | 8.11e-06 | 4 | 27 | 2 | CID000146782 | |
| Drug | eucalyptol | 8.11e-06 | 4 | 27 | 2 | ctd:C010087 | |
| Drug | SR 42641 | 8.11e-06 | 4 | 27 | 2 | CID000129049 | |
| Drug | territrem B | 8.11e-06 | 4 | 27 | 2 | CID000114734 | |
| Drug | 12(13)-EpOME | 8.68e-06 | 34 | 27 | 3 | CID000001416 | |
| Drug | TCEO | 8.68e-06 | 34 | 27 | 3 | CID000028167 | |
| Drug | AC1L1K7W | 8.68e-06 | 34 | 27 | 3 | CID000005377 | |
| Drug | AC1O5XSP | 8.68e-06 | 34 | 27 | 3 | CID006442739 | |
| Drug | cisapride | 8.92e-06 | 112 | 27 | 4 | CID000002769 | |
| Drug | AC1L1CJI | 9.49e-06 | 35 | 27 | 3 | CID000001929 | |
| Drug | pantoprazole | 9.49e-06 | 35 | 27 | 3 | CID000004679 | |
| Drug | 15-H-11,12-EETA | 1.03e-05 | 36 | 27 | 3 | CID011954042 | |
| Drug | AC1L3NGJ | 1.03e-05 | 36 | 27 | 3 | CID000092121 | |
| Drug | ICS-205,930 | 1.12e-05 | 37 | 27 | 3 | CID000005595 | |
| Drug | pentachlorophenol | 1.17e-05 | 120 | 27 | 4 | CID000000992 | |
| Drug | Malathion | 1.21e-05 | 121 | 27 | 4 | ctd:D008294 | |
| Drug | 11,14,15-THET | 1.32e-05 | 39 | 27 | 3 | CID006439531 | |
| Drug | sterigmatocystin | 1.32e-05 | 39 | 27 | 3 | CID005280389 | |
| Drug | azetidine-3-carboxylic acid | 1.35e-05 | 5 | 27 | 2 | CID000093192 | |
| Drug | Lindane | 1.35e-05 | 5 | 27 | 2 | DB00431 | |
| Drug | NSC-687962 | 1.35e-05 | 5 | 27 | 2 | CID000390521 | |
| Drug | Cao C | 1.35e-05 | 5 | 27 | 2 | CID000166617 | |
| Drug | oxanilide | 1.35e-05 | 5 | 27 | 2 | CID000069288 | |
| Drug | iso-THAO | 1.35e-05 | 5 | 27 | 2 | CID000127199 | |
| Drug | 6 beta-hydroxyprednisolone | 1.35e-05 | 5 | 27 | 2 | CID000152139 | |
| Drug | M 0772 | 1.35e-05 | 5 | 27 | 2 | CID000032485 | |
| Drug | 2Cmp | 1.35e-05 | 5 | 27 | 2 | CID000023392 | |
| Disease | tacrolimus measurement | 2.43e-09 | 4 | 26 | 3 | EFO_0008458 | |
| Disease | metabolonic lactone sulfate measurement | 5.83e-07 | 19 | 26 | 3 | EFO_0800659 | |
| Disease | estrone conjugate measurement | 4.47e-06 | 4 | 26 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 7.45e-06 | 5 | 26 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 7.45e-06 | 5 | 26 | 2 | EFO_0800569 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 1.12e-05 | 6 | 26 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 1.12e-05 | 6 | 26 | 2 | EFO_0800294 | |
| Disease | X-24574 measurement | 1.56e-05 | 7 | 26 | 2 | EFO_0800897 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 2.68e-05 | 9 | 26 | 2 | EFO_0800278 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 3.35e-05 | 10 | 26 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 3.35e-05 | 10 | 26 | 2 | EFO_0800289 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 4.09e-05 | 11 | 26 | 2 | EFO_0800295 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 4.09e-05 | 11 | 26 | 2 | EFO_0801531 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 4.90e-05 | 12 | 26 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 5.79e-05 | 13 | 26 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 5.79e-05 | 13 | 26 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 6.75e-05 | 14 | 26 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 6.75e-05 | 14 | 26 | 2 | EFO_0800283 | |
| Disease | sulfate measurement | 6.75e-05 | 14 | 26 | 2 | EFO_0007864 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 7.78e-05 | 15 | 26 | 2 | EFO_0800301 | |
| Disease | X-21410 measurement | 8.89e-05 | 16 | 26 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 8.89e-05 | 16 | 26 | 2 | EFO_0800305 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.13e-04 | 18 | 26 | 2 | EFO_0800288 | |
| Disease | etiocholanolone glucuronide measurement | 1.26e-04 | 19 | 26 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 1.40e-04 | 20 | 26 | 2 | EFO_0800317 | |
| Disease | X-24947 measurement | 1.71e-04 | 22 | 26 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 1.71e-04 | 22 | 26 | 2 | EFO_0021115 | |
| Disease | epiandrosterone sulfate measurement | 2.21e-04 | 25 | 26 | 2 | EFO_0021120 | |
| Disease | androsterone sulfate measurement | 3.88e-04 | 33 | 26 | 2 | EFO_0021117 | |
| Disease | X-12063 measurement | 5.76e-04 | 186 | 26 | 3 | EFO_0021283 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 7.88e-04 | 47 | 26 | 2 | DOID:783 (biomarker_via_orthology) | |
| Disease | urinary metabolite measurement | 1.28e-03 | 245 | 26 | 3 | EFO_0005116 | |
| Disease | dehydroepiandrosterone sulphate measurement | 1.64e-03 | 68 | 26 | 2 | EFO_0007001 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TWLLLAVSLVLLYLY | 11 | P20815 | |
| LLEWLFSFLLVLFLY | 31 | Q8IUA7 | |
| LIFNIFYWVIYKILR | 441 | O75311 | |
| VYLLWFLIQVLFYLL | 261 | Q14739 | |
| TWLLLAVSLVLLYLY | 11 | P08684 | |
| LYVWIFLLIFPFLLY | 36 | Q9H6A9 | |
| LEWQALLFVIFLLIY | 21 | Q8NGX0 | |
| WKYLDLATFILLYIL | 236 | Q9NYM4 | |
| YFWLFIEGLYLFTLL | 241 | P41586 | |
| YRWFAVLYLLVCFLL | 511 | Q06495 | |
| RAVQLLILLYFVWYV | 46 | Q9UBL9 | |
| LILLYFVWYVFIVQK | 51 | Q9UBL9 | |
| YFYSWLLNVLLGLLV | 286 | P42858 | |
| YVLWLLITAQIFSYL | 141 | O60266 | |
| VYFLFWTPYNIVILL | 251 | P41597 | |
| LIFNIFYWITYKIIR | 431 | P23416 | |
| FLWILLILLFEQYVT | 1411 | Q9H583 | |
| TWLLLAVSLILLYLY | 11 | P24462 | |
| TLYVSWLLYLFLILG | 101 | Q6J4K2 | |
| LFVFIYVQLWLVLRY | 56 | O60478 | |
| VIFFWLLVLYLLQVA | 136 | Q8N3S3 | |
| FLCLVVLYYIVWSLL | 181 | Q9H7F4 | |
| VLYYIVWSLLFLRSL | 186 | Q9H7F4 | |
| SYGYSFWLILLVILL | 176 | Q8NCR9 | |
| RLYLLWLLLVTLAYN | 216 | Q9NQW8 | |
| FWLLVEGLYLYTLLA | 231 | P32241 | |
| YRWLSYLLLFILDLV | 211 | Q9BSA4 | |
| WLIIYLKYLLFVFNF | 11 | A1L157 | |
| ACALQYYFLILWRIL | 996 | Q5T4S7 |